Amgen to Acquire Avidia
The merger and acquisition mania in the pharmaceutical industry continues unabated. Now, Amgen will acquire Avadia, a San Francisco area company that specializes in Avimer proteins for $380 million.
Chemical & Engineering News: Latest News - Amgen Will Acquire Protein Specialist Avidia:
AS I have stated before, I don’t see this activity abating anytime soon and it will likely continue into next year, especially in Europe.
Disclosure: I do own a few shares of Amgen.
Other Resources
• Amgen - Media - Press Release
• AMGEN TO ACQUIRE AVIDIA, A PRIVATELY HELD BIOPHARMACEUTICAL COMPANY IN THE SAN FRANCISCO BAY AREA
• Yahoo! News Search Results for Amgen Avidia
• Amgen Avidia - Google News
Technorati Tags: Amgen, pharma M&A, pharmaceutical deals, Avidia
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
